Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.
Pediatr Nephrol. 1996 Oct;10(5):590-3. doi: 10.1007/s004670050167.
Pediatr Nephrol. 1996.
PMID: 8897562
Clinical Trial.